Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 4,660.00
+10.00 (0.22%)
Oct 10, 2025, 3:30 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 163.91 billion as of October 10, 2025. Its market cap has decreased by -21.81% in one year.
Market Cap
163.91B
Enterprise Value
-184.40B
Revenue
74.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,660.00
Market Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 163.91B, a decrease of -39.09%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 163.56B | -10.40% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | 784.36B | 1,061.10% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.17T |
| Celltrion | 38.24T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,136.75B |
| Peptron | 6,866.96B |
| PharmaResearch | 5,631.19B |
| LigaChem Biosciences | 5,545.53B |